Numerous evidence has demonstrated that immunotherapy plays an important role in BC, and immunotherapy could alter or enhance the immune system when combined with everolimus, e.g., IL-15 gene therapy combined everolimus was reported useful for the treatment of metastatic BC 42. This evidence concerns the gene IL15 and breast cancer.